<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Leukemia/Lymphoma News</title> 
<link>http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/396</link> 
<description>Leukemia/Lymphoma</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2987390</link> 
<pubDate>12/20/2009</pubDate> 
<description><![CDATA[<b>Journal of Clinical Oncology</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2987390</guid>
</item> 


 

<item> 
<title><![CDATA[Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2988121</link> 
<pubDate>12/20/2009</pubDate> 
<description><![CDATA[<b>Haematologica</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2988121</guid>
</item> 
 
 


  


</channel> 
</rss>

